Lotepred T Eye Drop

Loteprednol etabonate acts by inhibiting the release of inflammatory mediators, thereby reducing redness, swelling, and discomfort, while Tobramycin effectively eradicates susceptible gram-negative and gram-positive bacterial pathogens. The combination offers dual therapeutic benefits by addressing both inflammation and infection simultaneously, minimizing the need for multiple medications.

Lotepred T Eye Drop is typically administered as one or two drops into the affected eye(s) every four to six hours, or as directed by a healthcare professional. Caution is advised in patients with a history of hypersensitivity to corticosteroids or aminoglycosides, and prolonged use should be avoided to reduce the risk of corticosteroid-induced ocular side effects such as increased intraocular pressure or cataract formation.

Proper hygiene and adherence to prescribed dosing are essential to ensure optimal therapeutic outcomes.